Management of Refractory Lupus Nephritis Based on New Guideline: Glomerular and Tubulointerstitial Disorders (KSN 2025) - Jun 19, 2025 - Abstract #GL01-S2; Pres time: Jun 20, 2025; 11:05 AM - 11:30 AM; Location: Room 1(GBR 101); "Promising options include obinutuzumab, anifrolumab, belimumab, and voclosporin. In this lecture, we will review the key updates in the 2024 KDIGO lupus nephritis guidelines and examine the clinical evidence supporting these changes. We will also explore real-world cases of refractory lupus nephritis and discuss practical examples of how the aforementioned therapies are being applied in clinical practice."
Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|